Navigation Links
Accuray Incorporated to Report Third Quarter Fiscal Year 2008 Financial Results
Date:4/14/2008

SUNNYVALE, Calif, April 14 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that it will report results for its third quarter fiscal year 2008, ending March 29, 2008, on Tuesday, April 29, 2008 after the market closes.

A conference call to review the results will begin at 2:00 p.m. PST (5:00 p.m. EST) and will be hosted by Euan S. Thomson, Ph.D., president and chief executive officer and Robert E. McNamara, senior vice president and chief financial officer.

The conference call dial-in numbers are (888) 724-9516 (USA) or (913) 312-0960(International), Access Code: 3304194. In addition, a dial-up replay of the conference call will be available beginning April 29, 2008 at 5:00 p.m. PDT (8:00 p.m. EDT) and ending on May 9, 2008. The replay telephone number is (888) 203-1112 (USA) or (719) 457-0820 (International), Access Code: 3304194.

A live webcast of the call will also be available from the Investor Relations section of the corporate Web site at http://www.accuray.com. A webcast replay can be accessed on the corporate Web site beginning on April 29, 2008 at approximately 5:00 p.m. PDT (8:00 p.m. EDT). The replay will remain available until Accuray announces its results for the fourth quarter of fiscal 2008, ending June 30, 2008.

About the CyberKnife(R) Robotic Radiosurgery System

The CyberKnife Robotic Radiosurgery System is the world's only robotic radiosurgery system designed to treat tumors anywhere in the body non- invasively. Using continual image guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for
'/>"/>

SOURCE Accuray Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Accurays CFO to Present at B. Riley & Company Ninth Annual Investor Conference
2. Accurays CyberKnife System Receives 2008 North American Medical Devices Product of the Year Award From Frost & Sullivan
3. Accuray Reports Continued Growth in Second Quarter of Fiscal 2008
4. Accuray Incorporated to Report Second Quarter Fiscal Year 2008 Financial Results
5. Accuray Exceeds 4,000 Lung Cancer Patients Treated with CyberKnife(R) System
6. Accuray Reports Record Revenue in First Quarter of Fiscal 2008
7. Accuray Announces Four New Products at Nations Leading Radiation Oncology Meeting
8. Accuray Incorporated to Host Investor and Analyst Meeting at ASTRO 2007
9. Accuray Incorporated to Report First Quarter Fiscal Year 2008 Financial Results
10. Accuray to Webcast Senior Management Presentations at Analyst Day Event
11. Accuray Incorporateds CEO to Speak at UBS Global Life Sciences Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... , , REDWOOD CITY, Calif., Dec. 4 /PRNew... GHDX ) today announced that the company will pres...an Antonio Breast Cancer Symposium (SABCS), taking...ez Convention Center. Four of the studies analyze...ression test that physicians currently use to pred...
(Date:12/4/2009)... , InfoLogic today announ...nning multi-purpose equation editor. With a focus ... Personal Edition is a standalone equation editor ...reads and writes various industry standard mathema...ion 4.8 adds support for Google Docs and Zoho Writ...
(Date:12/4/2009)... , North American Seminar...sh to host continuing medical education courses at...ws a facility to showcase its operation and capabi...their overall costs to educate their physical ther... over 45 facilities hosted over 250 live training ...
(Date:12/4/2009)... , Plantar fasciitis heel...d Stated each year, and cold therapy has been cite...s an effective treatment option. In response to t...election of compressive cold therapy systems for p...line of combination night splint therapies. , ...
(Date:12/4/2009)... , The renowned Center fo.... is now offering the only natural immuno-boosting...rinciples of Ayurveda. , ...In this age of unprecedented illness due to factor...influenza strain millions of people around the wor...
Breaking Medicine News(10 mins):Health News:Genomic Health to Present Five New Studies at 32nd Annual San Antonio Breast Cancer Symposium 2Health News:Genomic Health to Present Five New Studies at 32nd Annual San Antonio Breast Cancer Symposium 3Health News:Genomic Health to Present Five New Studies at 32nd Annual San Antonio Breast Cancer Symposium 4Health News:MathMagic Personal 4.8 for Windows Now Supports Google Docs and Zoho Equation 2Health News:MathMagic Personal 4.8 for Windows Now Supports Google Docs and Zoho Equation 3Health News:MathMagic Personal 4.8 for Windows Now Supports Google Docs and Zoho Equation 4Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 2Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 3Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 4Health News:Orthotics And Beyond Introduces Compressive Cold Therapy Products for Plantar Fasciitis Treatment 2Health News:The Chopra Center for Wellbeing Launches Vedamune: An Ayurvedic Supplement to Support The Immune System 2
...6 A large new study provides evidence that long... women from Parkinson,s disease. The study was rel...Academy of Neurology,s 61st Annual Meeting in Seat...pause) had a lower risk of developing the disease ...
... 26 The following release was issued today by the...eeks after federal vaccine court ruled against thr...ir children, Huffington Post writers Robert F Ke... week, Banks, parents were awarded a lump sum of m...
.... 26 A recent decision issued by the U.S. Distr...uld have significant implications for the insuranc...ict Judge Richard J. Holwell clarifies a decision ...defense costs incurred in connection with covered ...
...nesiology investigator Dustin Hittel, PhD, has pro...duces large amounts of a protein called myostatin,...hat for Type 2 diabetics, and the very obese, the ...ne which controls myostatin results in doublemuscl...
...e powerful chemotherapy and radiation used to save...tility. , Research in a new field called oncofer...erve the reproductive health of women, men and chi...y researcher and a breast surgical oncologist from...
...26 With sensational headlines about multiple birt...e fact that infertility is a painful reality for m...e than 7.3 million Americans struggle with fertili...ed economy, reproductive medicine is thriving, and...
Other Medicine News:Health News:Reproductive Factors May Protect Women from Parkinson's Disease 2Health News:Reproductive Factors May Protect Women from Parkinson's Disease 3Health News:On the Heels of Court Ruling Denying Autism-Vaccine Link, U.S. Federal Court Declares MMR Vaccine Caused Autism in a Young Boy 2Health News:Patton Boggs Wins Landmark Insurance Case for Client 2Health News:New tool guides doctors to save cancer patients' fertility 2Health News:New tool guides doctors to save cancer patients' fertility 3Health News:A Recession-Resistant Business? Introducing FertilityAuthority.com 2
(Date:12/4/2009)...DA, Md., Dec. 4 Drs. Neal Shore an...-specific antigen (PSA) recurrence from the additi...al recurrence rate in a Phase III pivotal study of...or monthly leuprolide in prostate cancer patients ...er patients who received FIRMAGON 240/80 mg/month ...
(Date:12/4/2009)...AN, N.J., Dec. 4 Depression, anxie...yperactivity Disorder (ADHD), sleep disorder and m...d to occur more often in people who said they had ...an epilepsy diagnosis, according to a survey of ap..., Findings from " CNS-Related Comorbidities in In...
(Date:12/3/2009)...O VIEJO, Calif. and STATE COLLEGE, Pa., Dec. 3 /PR... announced the signing of an agreement to provide ...ftGenetics, NextGENe software for next-generation ...ogo: http://www.newscom.com/cgi-bin/prnh/2009042...s CSO said, "Our team at Ambry has been providing ...
Breaking Medicine Technology:Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3Senesco Technologies Inc Announces Management Change 14857 1Senesco Technologies Inc Announces Management Change 14857 2Senesco Technologies Inc Announces Management Change 14857 3Cyberonics Provides Update on Tax Position 6313 1Cyberonics Provides Update on Tax Position 6313 2Cyberonics Provides Update on Tax Position 6313 3Cyberonics Provides Update on Tax Position 6313 4Retirement Living TV Premieres Season Two of Whole Body Health 6310 1Retirement Living TV Premieres Season Two of Whole Body Health 6310 2
...Aug. 8 Lixte,Biotechnology Holdings, Inc. (OTC Bu...ounds from each of two different types of drugs be...types of brain cancers have,activity against human.... Kovach, President and CEO of Lixte, said, "Lixte... of two different classes of,pharmacologic agents ...
... 7 ProteoTech Inc. (ProteoTech),today announced t...w Drug,(IND) requirements and has been cleared by ...al on Exebryl-1(R), a novel small molecule drug ta...r the treatment of Alzheimer,s,disease. ProteoTech...8., At the 2008 International Conference on Alzhe...
Other Medicine Technology:Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer 2ProteoTech's Exebryl-1(R) Enters Human Clinical Trials for the Treatment of Alzheimer's Disease 2
Sabre 2400 Electrosurgery Generator, 110V, 60Hz
ExcaliburPlus PC Electrosurgery Generator, 220V, 50Hz
Bipolar Generator
Finesse Electrosurgical Generator (200-240 VAC)
Medicine Products: